Bayer finds growing market for its weed killer in Latin America as court ruling looms

The cancer controversy over Roundup isn’t going anywhere as market expands

This column is for Callaway Climate Insights subscribers only, but it’s OK to share once in a while. Was it shared with you? Please subscribe.

(Michael Molinski is a senior economist at Trendline Economics. He’s worked for Fidelity, Charles Schwab and Wells Fargo, and previously as a foreign correspondent and editor for Bloomberg News and MarketWatch.)

NEW YORK (Callaway Climate Insights) — The U.S. Supreme Court is expected to rule next month on the landmark case against Bayer’s weedkiller Roundup, which could either double the amount of lawsuits it faces or lead to the dismissal of tens of thousands of lawsuits claiming it causes cancer.

But in the meantime, German-based Bayer and rival Chinese-owned Syngenta have found a more lucrative region of the world to market glyphosate which doesn’t face as many judicial or government obstacles — Latin America.